Patient Assistance Programs

What Are Patient Assistance Programs?

Patient assistance programs (PAPs) are programs run by pharmaceutical manufacturers, nonprofit organizations, or government agencies that provide free or significantly discounted prescription medications to patients who cannot afford them. PAPs are one of the most impactful — and underutilized — tools available to patients facing high drug costs.

Estimates suggest that fewer than 1 in 3 eligible patients who could benefit from a PAP actually enrolls in one, often because they are unaware the programs exist or find the application process daunting. This guide aims to demystify the process and help you access the help you're entitled to.

Manufacturer PAPs

Nearly every major pharmaceutical manufacturer operates at least one patient assistance program. These programs are designed primarily for uninsured patients or those with insurance that does not cover the medication in question. They provide the brand-name drug either free of charge or at a nominal co-pay.

Examples of well-known manufacturer PAPs include:

• Pfizer RxPathways: Covers eligible Pfizer medications for uninsured and underinsured patients.
• Lilly Insulin Value Program: Caps insulin cost at $35 per month for eligible patients.
• Bristol Myers Squibb Access Support: Covers BMS medications for commercially insured and uninsured patients.
• AstraZeneca AZ&Me: Provides free AstraZeneca medications to qualifying uninsured or underinsured patients.
• Novo Nordisk Patient Assistance Program: Covers insulin and other Novo Nordisk diabetes products.

Most large drug companies have dedicated patient assistance websites. The NeedyMeds database (needymeds.org) and RxAssist (rxassist.org) aggregate PAP information across manufacturers into searchable databases.

Who Qualifies?

Eligibility criteria vary by program and manufacturer, but most PAPs share several common requirements:

• Income threshold: Most programs use a multiple of the Federal Poverty Level (FPL) as the cutoff. Common thresholds range from 200% to 400% FPL, though some programs have higher limits. For 2024, 400% FPL is approximately $60,000 for an individual.
• Insurance status: Most manufacturer PAPs are designed for uninsured patients or those without prescription drugPrescription Drug

  A medication that legally requires a healthcare provider's prescription before dispensing. Prescription-only status is assigned when a drug's risks require professional supervision — due to side effec

  coverage for the specific medication. Some extend to underinsured patients whose copay burden is excessive.
• Residency: Most programs require US residency and often citizenship or documented legal immigration status.
• Prescription: A valid prescription from a licensed US healthcare provider is required.

Do not assume you won't qualify because you have insurance or have some income. Income thresholds for specialty drug PAPs are often higher than people expect, and underinsurance (having coverage that nonetheless leaves you with unaffordable out-of-pocket costs) is a qualifying criterion for many programs.

How to Apply

The application process typically involves the following steps:

1. Identify the program: Search the manufacturer's website for their PAP, or use a database like NeedyMeds or Partnership for Prescription Assistance (pparx.org) to find programs covering your medication.

2. Gather documentation: Most applications require proof of income (recent tax return, pay stubs, or a signed income declaration), proof of insurance status (or lack thereof), and a completed prescription from your provider.

3. Involve your prescriber: Many PAP applications require your prescriber to sign a section of the form. Social workers in clinic settings often assist with this process and may know about programs you have not found.

4. Submit and follow up: Applications can take 2–6 weeks to process. Many programs can provide a bridge supply of medication while the application is pending, particularly for urgent situations.

5. Renew annually: Most PAPs require annual re-enrollment with updated income documentation.

Many hospitals and specialty clinics employ social workers or patient navigators whose job includes helping patients enroll in assistance programs. If you are a patient at a large health system, ask to be connected with these resources.

Independent Charitable Foundations

Beyond manufacturer PAPs, a network of independent charitable foundations provides financial assistance for medication costs. Unlike manufacturer programs, these organizations typically assist with medications from multiple companies and can help insured patients with copays and premiums.

Key foundations include:

• Patient Advocate Foundation Co-Pay Relief (PAF CPR): Disease-specific funds covering copays for a range of conditions.
• HealthWell Foundation: Copay assistance for insured patients with chronic or life-altering conditions.
• Patient Services Inc. (PSI): Premium and copay assistance for specific diseases.
• CancerCare Co-Payment Assistance Foundation: Copay help for patients receiving chemotherapy.
• National Organization for Rare Disorders (NORD): Disease-specific assistance funds for rare disease patients.

These foundations receive donations from manufacturers, which has prompted questions about their independence, but they do provide genuine financial relief to patients. Fund availability can fluctuate; if a fund is currently closed, ask to be placed on a waiting list or check back in 30–60 days.

State Pharmaceutical Assistance Programs

Many US states operate their own pharmaceutical assistance programs, typically targeting elderly or disabled residents who fall into a gap between Medicaid eligibility and affordable private insurance. These programs vary dramatically in eligibility, covered drugs, and benefit levels.

Examples include PACE (Pennsylvania), EPIC (New York), SPAP (New Jersey), and SHIPS (Illinois). To find your state's program, search "[state name] pharmaceutical assistance program" or contact your State Health Insurance Assistance Program (SHIP) counselor, a free federally funded resource.

Rare Disease and Orphan DrugOrphan Drug

A drug developed to treat a rare disease or condition affecting fewer than 200,000 people in the United States. The Orphan Drug Act provides manufacturers with incentives including tax credits, grant

Support

For patients with rare diseases treated by orphan drugs — medications developed for conditions affecting fewer than 200,000 Americans — specialized support programs are often available because the patient population is small and medication costs are frequently extreme.

NORD maintains a patient services database with disease-specific financial assistance information. Disease-specific nonprofit organizations (e.g., the Cystic Fibrosis Foundation, the National MPS Society) often maintain their own assistance programs or can connect patients with manufacturer programs tailored to their condition.

Copay Cards vs. PAPs

Copay assistance cards (also called copay cards or patient savings cards) are distinct from PAPs and are worth understanding separately:

• Copay cards are issued by manufacturers for brand-name drugs. They reduce or eliminate the copay for commercially insured patients, effectively covering the patient's share of the drug cost. They are quick to activate (often instantly at the pharmacy) but are not available to Medicare or Medicaid beneficiaries, who must use other programs.
• PAPs provide the medication itself, free or at low cost, to uninsured or underinsured patients after an application process.

If you have commercial insurance, a copay card may be the fastest path to relief. If you are uninsured, a PAP is the route to pursue. If you are on Medicare, explore the Extra Help (Low Income Subsidy) program through the Social Security Administration, which significantly reduces Part D costs for qualifying beneficiaries.

Do not leave these resources unused. The programs exist precisely because manufacturers, payers, and policymakers recognize that list prices can be unmanageable, and they represent real, available help.

This guide is for educational purposes only. It does not replace professional medical advice. Always consult your healthcare provider before making changes to your medication regimen.